Oxford Innovation Finance
VC Fund
Oxford, United States
Oxford Innovation Finance is a VC fund in Oxford focused on Biotechnology and Health Care. Oxford Innovation Finance is home to OION, one of the oldest and largest angel investment networks in the UK.
- Total investments:
- 9
- Last investment:
- Lead investor:
- 11%
Last updated:
For AI agents: llms.txt
Industries Oxford Innovation Finance invests in
Stages Oxford Innovation Finance invests in
Countries Oxford Innovation Finance invests in
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Chris Oliver
|
|||
Investment Focus
Industry
- Biotechnology 3 (33%)
- Health Care 2 (22%)
- Medical 1 (11%)
- Chemical 1 (11%)
- Hardware 1 (11%)
Stage
- Venture - Series Unknown 5 (56%)
- Seed 3 (33%)
- Pre-Seed 1 (11%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
Chris Oliver
Investment Principal
|
Investment Principal | Total investments: 1 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Circular 11
|
Circular 11 uses low-grade plastic waste in-order to create building materials and end-use products. | $3.2M / Venture - Series Unknown / Jun 01, 2026 | |
Semarion
|
Semarion is a spin-out company from the Cavendish Laboratory at the University of Cambridge, operating at the edge of the physical and life sciences. Semarion combines microchip industry materials and techniques engineering and cell biology to tackle unmet drug screening needs. | $3.8M / Venture - Series Unknown / Mar 31, 2026 | |
Navlive
|
NavLive creates instant 2D and 3D models, along with accurate site surveys using user-friendly Scan-to-BIM functionality. | $4.5M / Seed / May 29, 2025 | |
Gardin
|
Gardin develops optical phenotyping technology and analytics to optimise food production. | $4.5M / Seed / May 07, 2025 | |
OSSTEC
|
OSSTEC is bringing advanced technology to the operating room with metal 3D printed bone healing implants. The orthopaedic implants emulate natural bone structure and address high failure rates of existing implants, keeping patients who suffer with osteoarthritis healthy, active and enjoying life. | $3.2M / Seed / Mar 30, 2025 | |
Wilder Sensing
|
Wilder Sensing is a nature technology business that uses artificial intelligence to quantify biodiversity changes. | $887.4K / Pre-Seed / Dec 12, 2024 | |
Iota Sciences
|
Iota Sciences is develops technologies with unique capabilities to advance discovery into cell biology. | Venture - Series Unknown / Jul 31, 2024 | |
Oxford Space Systems
|
Oxford Space Systems is a multi-award-winning, record-breaking venture capital backed, space tech business that's developing a new generation of deployable antennas and space structures for the global satellite industry. Using both innovative design techniques such as origami and novel proprietary materials developed by the company, OSS'structures are lighter, less complex and lower cost than alternatives in commercial demand. Founded in late 2013, OSS set a record for the space sector with it's AstroTube Boom: the fastest development of a new product from concept to successful deployment on orbit in under 30 months. Today, the 18 strong and growing OSS team is a diverse mix of international graduates and experienced space industry professionals, with over 100 years of combined space sector experience. OSS investors include a small syndicate of UK venture capital funds together US based investors, Space Angels. Oxford Space Systems has successfully completed a number of UK government supported co-developments with leading European satellite builders as well straight commercial contracts in both Asia and the US. As part of its planned expansion, OSS move into its own custom facility at the Harwell Space Cluster in August 2018, giving it the largest clean room at the cluster. The facility will meet required security standards to undertake UK government defense & security contracts. . | $4M / Venture - Series Unknown / May 16, 2024 | |
Hexigone Inhibitors
|
Hexigone aims to replace toxic chemicals used in the anti-corrosion market with our disruptive, novel, micro/nano reservoir technologies, creating 'smart' coatings. Our additives will enable the coatings to protect for longer in an intelligent manner, increasing the lifetime cycle of the end product, reducing the drain on primaryresources. | $999.1K / Venture - Series Unknown / Apr 30, 2024 |
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does Oxford Innovation Finance invest in?
Oxford Innovation Finance invests primarily in Biotechnology, Health Care and Medical startups, most often at Venture - Series Unknown and Seed stage. Most of the 9 investments tracked by Shizune back companies in United Kingdom. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Oxford Innovation Finance?
Public channels for Oxford Innovation Finance include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Oxford Innovation Finance?
The team at Oxford Innovation Finance includes Chris Oliver (Investment Principal). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
